Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Epirubicin × Gynecologic × Clear all

Phase

Status

Completed 4 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 21 Lymphoid 1 Gynecologic 1 Genitourinary 1

Conditions

Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 69 pembrolizumab 58 Carboplatin 58 Bevacizumab 49 Cisplatin 39 Specimen Handling 30 Drug Therapy 22 olaparib 21 Blood Specimen Collection 21 Biopsy 19 Magnetic Resonance Spectroscopy 18 Cyclophosphamide 15 Taxes 14 Letrozole 14 niraparib 13 fludarabine 12 Gemcitabine 12 liposomal doxorubicin 10 abemaciclib 10 Radiotherapy 10 Fulvestrant 10 dostarlimab 9 Nivolumab 9 Doxorubicin 9 Docetaxel 9 Brachytherapy 9 mirvetuximab soravtansine 8 lenvatinib 8 camrelizumab 8 Topotecan 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03025477 2021-02-11

CHIMOVIP

Groupe Hospitalier Diaconesses Croix Saint-Simon

Phase 2 Recruiting

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡